interleucina-7 (il-7)

The invention relates to the use of Interleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load.

Saved in:
Bibliographic Details
Main Authors STEPHANIE BEQ, PIERRE DEMOL, MICHEL MORRE, THÉRÉSE CROUGHS, BRIGITTE ASSOULINE
Format Patent
LanguagePortuguese
Published 21.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the use of Interleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load.
Bibliography:Application Number: BR20141102365